Education
About Us
Working with TipRanks
Follow Us
COSMO Pharmaceuticals N.V. (DE:C43)
FRANKFURT:C43
Total Valuation
COSMO Pharmaceuticals N.V. has a market cap or net worth of €2.25B. The enterprise value is €1.94B.
Market Cap€2.25B
Enterprise Value€1.94B
Share Statistics
COSMO Pharmaceuticals N.V. has 17,543,522 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding17,543,522
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
COSMO Pharmaceuticals N.V.’s return on equity (ROE) is 0.27 and return on invested capital (ROIC) is 21.57%.
Return on Equity (ROE)0.27
Return on Assets (ROA)0.21
Return on Invested Capital (ROIC)21.57%
Return on Capital Employed (ROCE)0.25
Revenue Per Employee831.12K
Profits Per Employee477.78K
Employee Count321
Asset Turnover0.41
Inventory Turnover1.47
Valuation Ratios
The current PE Ratio of COSMO Pharmaceuticals N.V. is 39.7. COSMO Pharmaceuticals N.V.’s PEG ratio is -0.00305.
PE Ratio39.7
PS Ratio4.15
PB Ratio2.22
Price to Fair Value2.22
Price to FCF7.07
Price to Operating Cash Flow31.06
PEG Ratio-0.00305
Income Statement
In the last 12 months, COSMO Pharmaceuticals N.V. had revenue of 266.79M and earned 133.24M in profits. Earnings per share was 8.15.
Revenue266.79M
Gross Profit246.92M
Operating Income148.88M
Pretax Income153.37M
Net Income133.24M
EBITDA165.71M
Earnings Per Share (EPS)8.15
Cash Flow
In the last 12 months, operating cash flow was 64.13M and capital expenditures -6.85M, giving a free cash flow of 57.28M billion.
Operating Cash Flow64.13M
Free Cash Flow57.28M
Free Cash Flow per Share3.26
Dividends & Yields
COSMO Pharmaceuticals N.V. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.40
52-Week Price Change110.27%
50-Day Moving Average108.32
200-Day Moving Average75.36
Relative Strength Index (RSI)73.89
Average Volume (3m)48.00
Important Dates
COSMO Pharmaceuticals N.V. upcoming earnings date is Mar 9, 2026, Before Open (Confirmed).
Last Earnings DateJul 23, 2025
Next Earnings DateMar 9, 2026
Ex-Dividend Date―
Financial Position
COSMO Pharmaceuticals N.V. as a current ratio of 4.19, with Debt / Equity ratio of 0.59%
Current Ratio4.19
Quick Ratio3.91
Debt to Market Cap<0.01
Net Debt to EBITDA-0.25
Interest Coverage Ratio1.30K
Taxes
In the past 12 months, COSMO Pharmaceuticals N.V. has paid 20.18M in taxes.
Income Tax20.18M
Effective Tax Rate0.13
Enterprise Valuation
COSMO Pharmaceuticals N.V. EV to EBITDA ratio is 6.44, with an EV/FCF ratio of 6.80.
EV to Sales4.00
EV to EBITDA6.44
EV to Free Cash Flow6.80
EV to Operating Cash Flow6.57
Balance Sheet
COSMO Pharmaceuticals N.V. has €126.63M in cash and marketable securities with €2.70M in debt, giving a net cash position of €123.93M billion.
Cash & Marketable Securities€126.63M
Total Debt€2.70M
Net Cash€123.93M
Net Cash Per Share€7.06
Tangible Book Value Per Share€9.12
Margins
Gross margin is 87.77%, with operating margin of 55.81%, and net profit margin of 49.94%.
Gross Margin87.77%
Operating Margin55.81%
Pretax Margin57.49%
Net Profit Margin49.94%
EBITDA Margin62.11%
EBIT Margin57.51%
Analyst Forecast
The average price target for COSMO Pharmaceuticals N.V. is €148.97, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target€148.97
Price Target Upside18.23% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast―
EPS Growth Forecast―